ATE382687T1 - Verfahren zur stellengerichteten mutagenese und gezielten randomisierung - Google Patents

Verfahren zur stellengerichteten mutagenese und gezielten randomisierung

Info

Publication number
ATE382687T1
ATE382687T1 AT04703064T AT04703064T ATE382687T1 AT E382687 T1 ATE382687 T1 AT E382687T1 AT 04703064 T AT04703064 T AT 04703064T AT 04703064 T AT04703064 T AT 04703064T AT E382687 T1 ATE382687 T1 AT E382687T1
Authority
AT
Austria
Prior art keywords
site
directed mutagenesis
targeted randomization
randomization
targeted
Prior art date
Application number
AT04703064T
Other languages
English (en)
Inventor
Chris Leeflang
Der Kleij Wilhelmus Van
Original Assignee
Genencor Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32771864&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE382687(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genencor Int filed Critical Genencor Int
Application granted granted Critical
Publication of ATE382687T1 publication Critical patent/ATE382687T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04703064T 2003-01-16 2004-01-16 Verfahren zur stellengerichteten mutagenese und gezielten randomisierung ATE382687T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44079203P 2003-01-16 2003-01-16

Publications (1)

Publication Number Publication Date
ATE382687T1 true ATE382687T1 (de) 2008-01-15

Family

ID=32771864

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04703064T ATE382687T1 (de) 2003-01-16 2004-01-16 Verfahren zur stellengerichteten mutagenese und gezielten randomisierung

Country Status (7)

Country Link
US (1) US20060252155A1 (de)
EP (1) EP1587924B2 (de)
AT (1) ATE382687T1 (de)
CA (1) CA2513227C (de)
DE (1) DE602004011017T3 (de)
DK (1) DK1587924T4 (de)
WO (1) WO2004064744A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011004801A (es) 2008-11-11 2011-06-16 Danisco Inc Composiciones y metodos que comprenden una variante de subtilisina.
WO2010056671A1 (en) 2008-11-11 2010-05-20 Danisco Us Inc. Compositions and methods comprising a subtilisin variant
PL2558573T3 (pl) 2010-04-15 2017-08-31 Danisco Us Inc. Kompozycje i sposoby obejmujące warianty proteazy
EP4525615A2 (de) 2022-05-14 2025-03-26 Novozymes A/S Zusammensetzungen und verfahren zur prävention, behandlung, unterdrückung und/oder beseitigung von phytopathogenen befällen und infektionen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182204A (en) * 1984-05-29 1993-01-26 Genencor International, Inc. Non-human carbonyl hydrolase mutants, vectors encoding same and hosts transformed with said vectors
US5418873A (en) * 1993-09-09 1995-05-23 Digisonix, Inc. Active acoustic attenuation system with indirect error sensing
US5693506A (en) 1993-11-16 1997-12-02 The Regents Of The University Of California Process for protein production in plants
US5776746A (en) * 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods
US20030162209A1 (en) * 2001-12-19 2003-08-28 George Martin PCR based high throughput polypeptide screening

Also Published As

Publication number Publication date
CA2513227A1 (en) 2004-08-05
DK1587924T4 (da) 2012-04-02
DE602004011017T3 (de) 2012-06-06
WO2004064744A3 (en) 2004-11-04
DK1587924T3 (da) 2008-05-13
WO2004064744A2 (en) 2004-08-05
US20060252155A1 (en) 2006-11-09
EP1587924A2 (de) 2005-10-26
EP1587924A4 (de) 2006-05-10
DE602004011017T2 (de) 2008-12-24
EP1587924B2 (de) 2012-01-18
DE602004011017D1 (de) 2008-02-14
EP1587924B1 (de) 2008-01-02
CA2513227C (en) 2012-09-11

Similar Documents

Publication Publication Date Title
IL226717A (en) Isolated nucleic acids encoded by anti-beta human antibodies 7
TW200732349A (en) Anti-OX40L antibodies and methods using same
WO2019148026A8 (en) Il-22 fc fusion proteins and methods of use
TW200716647A (en) Synthesis of (R)-N-methylnaltrexone
WO2008127290A3 (en) Alginate and alginate lyase compositions and methods of use
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
ATE554105T1 (de) Veränderte antikörper
ATE537263T1 (de) Kationische lipide und verwendungsverfahren
TW200716646A (en) (S)-N-methylnaltrexone
WO2005005679A3 (en) Super-hydrophobic surfaces, methods of their construction and uses therefor
EP1844077A4 (de) Dr5-antikörper und deren verwendung
MX385834B (es) Composiciones relacionadas con una toxina de clostridium difficile mutante y sus metodos.
BRPI0414599A (pt) pirrol-indóis substituìdos
ATE497492T1 (de) Reinigung von montelukast
WO2008057550A3 (en) Stabilization of vaccines by lyophilization
WO2004032882A3 (en) Chemical compounds
ATE448775T1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
DE602004017486D1 (de) Substituierte heteroarylbenzofuransäuren
TW200624426A (en) BACE inhibitors
PH12013502194A1 (en) Antibodies to egfl7 and methods for their use
NO20063196L (no) Nye fusjonerte pyrrolokarbazoler
NO20063193L (no) Fusjonerte pyrrolokarbazoler og fremgangsmater for fremstilling derav
MY144970A (en) Heterocyclic compounds
WO2005040107A3 (en) Methods for making simvastatin and intermediates
MXPA03007413A (es) Composicion y metodo para tratar enfermedades inflamatorias.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties